Advertising; prohibiting certain direct-to-consumer advertising by pharmaceutical companies; creating felony offense. Effective date. Emergency.

SB 771 prohibits Oklahoma pharmaceutical companies from advertising prescription drugs directly to consumers through TV, radio, social media, print, or digital platforms. Violations would be classified as felonies, carrying penalties of up to $500,000 fines or five years in prison per offense. The law includes exceptions for healthcare provider educational materials, public health campaigns (not promoting specific drugs), clinical trial information, and insurance coverage details. It takes effect July 1, 2025, and is declared an emergency. The bill aims to align Oklahoma with global norms by restricting advertising practices linked to rising drug costs and health risks.